1. Home
  2. WS vs GENB Comparison

WS vs GENB Comparison

Compare WS & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

SELL

Current Price

$37.52

Market Cap

2.0B

Sector

N/A

ML Signal

SELL

Logo Generate Biomedicines Inc. Common Stock

GENB

Generate Biomedicines Inc. Common Stock

HOLD

Current Price

$9.84

Market Cap

1.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
GENB
Founded
1955
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2023
2026

Fundamental Metrics

Financial Performance
Metric
WS
GENB
Price
$37.52
$9.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $27.00
AVG Volume (30 Days)
328.4K
★ 868.3K
Earning Date
12-16-2026
11-12-2026
Dividend Yield
★ 1.74%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $3,443,800,000.00
N/A
Revenue This Year
$11.55
N/A
Revenue Next Year
$0.38
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 11.33
N/A
52 Week Low
$27.22
$10.38
52 Week High
$49.17
$22.67

Technical Indicators

Market Signals
Indicator
WS
GENB
Relative Strength Index (RSI) 44.40 32.70
Support Level $36.04 N/A
Resistance Level $39.42 $14.33
Average True Range (ATR) 2.38 1.20
MACD -0.48 -0.34
Stochastic Oscillator 18.51 0.89

Price Performance

Historical Comparison
WS
GENB

About WS Worthington Steel Inc.

Worthington Steel Inc is a value-added metals processors with the ability to provide a diversified products and services that span a variety of end markets. It is a value-added processor of carbon flat-rolled steel and a producer of laser welded solutions and electrical steel laminations. It is one of the independent intermediate processors of carbon flat-rolled steel in the U.S. It occupy a niche in the steel industry by focusing on products requiring exact specifications. The company has one operating and reportable segment. It has presence in United States, Canada, Mexico, and Rest of world. The company has majority of sales from United States.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: